![Affinity-selected heparan sulfate collagen device promotes periodontal regeneration in an intrabony defect model in Macaca fascicularis | Scientific Reports Affinity-selected heparan sulfate collagen device promotes periodontal regeneration in an intrabony defect model in Macaca fascicularis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-023-38818-y/MediaObjects/41598_2023_38818_Fig1_HTML.png)
Affinity-selected heparan sulfate collagen device promotes periodontal regeneration in an intrabony defect model in Macaca fascicularis | Scientific Reports
![Patterns of Carbon-Bound Exogenous Compounds Impact Disease Pathophysiology in Lung Cancer Subtypes in Different Ways | ACS Nano Patterns of Carbon-Bound Exogenous Compounds Impact Disease Pathophysiology in Lung Cancer Subtypes in Different Ways | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.2c11161/asset/images/large/nn2c11161_0009.jpeg)
Patterns of Carbon-Bound Exogenous Compounds Impact Disease Pathophysiology in Lung Cancer Subtypes in Different Ways | ACS Nano
Synthesis, Structure–Activity Relationships, Radiofluorination, and Biological Evaluation of [18F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET | Journal of Medicinal Chemistry
![Classification of hardware, software, and materials used in some of the... | Download Scientific Diagram Classification of hardware, software, and materials used in some of the... | Download Scientific Diagram](https://www.researchgate.net/publication/354420472/figure/tbl1/AS:1065468383227904@1631038866516/Classification-of-hardware-software-and-materials-used-in-some-of-the-publications-in.png)
Classification of hardware, software, and materials used in some of the... | Download Scientific Diagram
![Frontiers | Immunometabolism of Tissue-Resident Macrophages – An Appraisal of the Current Knowledge and Cutting-Edge Methods and Technologies Frontiers | Immunometabolism of Tissue-Resident Macrophages – An Appraisal of the Current Knowledge and Cutting-Edge Methods and Technologies](https://www.frontiersin.org/files/MyHome%20Article%20Library/665782/665782_Thumb_400.jpg)
Frontiers | Immunometabolism of Tissue-Resident Macrophages – An Appraisal of the Current Knowledge and Cutting-Edge Methods and Technologies
![Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis During Induction Phase: A Systematic Review and Network Meta-Analysis - C. Cameron, C. Druchok, B. Hutton, S. McElligott, S. Nair, A. Schubert, A. Situ, Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis During Induction Phase: A Systematic Review and Network Meta-Analysis - C. Cameron, C. Druchok, B. Hutton, S. McElligott, S. Nair, A. Schubert, A. Situ,](https://journals.sagepub.com/cms/10.1177/2475530318818816/asset/images/large/10.1177_2475530318818816-fig1.jpeg)
Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis During Induction Phase: A Systematic Review and Network Meta-Analysis - C. Cameron, C. Druchok, B. Hutton, S. McElligott, S. Nair, A. Schubert, A. Situ,
![Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism | Nature Communications Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-023-38501-w/MediaObjects/41467_2023_38501_Fig1_HTML.png)
Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism | Nature Communications
![Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials - The Lancet Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials - The Lancet](https://www.thelancet.com/cms/attachment/5b4256a3-bfbc-4633-8341-2decf32ef3ff/gr2_lrg.jpg)
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials - The Lancet
![Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study - The Lancet Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study - The Lancet](https://www.thelancet.com/cms/attachment/2092108136/2076395957/gr1.gif)
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study - The Lancet
![Biocompatibility and Surface Roughness of Different Sustainable Dental Composite Blocks: Comprehensive In Vitro Study | ACS Omega Biocompatibility and Surface Roughness of Different Sustainable Dental Composite Blocks: Comprehensive In Vitro Study | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.2c03745/asset/images/large/ao2c03745_0009.jpeg)
Biocompatibility and Surface Roughness of Different Sustainable Dental Composite Blocks: Comprehensive In Vitro Study | ACS Omega
![A novel inducible prophage from the mycosphere inhabitant Paraburkholderia terrae BS437 | Scientific Reports A novel inducible prophage from the mycosphere inhabitant Paraburkholderia terrae BS437 | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-09317-8/MediaObjects/41598_2017_9317_Fig1_HTML.jpg)
A novel inducible prophage from the mycosphere inhabitant Paraburkholderia terrae BS437 | Scientific Reports
![Biology | Free Full-Text | VCAM-1 Target in Non-Invasive Imaging for the Detection of Atherosclerotic Plaques Biology | Free Full-Text | VCAM-1 Target in Non-Invasive Imaging for the Detection of Atherosclerotic Plaques](https://pub.mdpi-res.com/biology/biology-09-00368/article_deploy/html/images/biology-09-00368-g001.png?1606238888)
Biology | Free Full-Text | VCAM-1 Target in Non-Invasive Imaging for the Detection of Atherosclerotic Plaques
![Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape - The Lancet Infectious Diseases Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/d239096f-2052-40ee-9835-2b029b56e9a3/gr1_lrg.jpg)